| Literature DB >> 30349117 |
Tammi C Vesth1, Jane L Nybo1, Sebastian Theobald1, Jens C Frisvad1, Thomas O Larsen1, Kristian F Nielsen1, Jakob B Hoof1, Julian Brandl1, Asaf Salamov2, Robert Riley2,3, John M Gladden4,5, Pallavi Phatale4,6, Morten T Nielsen1, Ellen K Lyhne1, Martin E Kogle1, Kimchi Strasser7, Erin McDonnell7, Kerrie Barry2, Alicia Clum2, Cindy Chen2, Kurt LaButti2, Sajeet Haridas2, Matt Nolan2, Laura Sandor2, Alan Kuo2, Anna Lipzen2, Matthieu Hainaut8,9, Elodie Drula8,9, Adrian Tsang7, Jon K Magnuson4,6, Bernard Henrissat8,9,10, Ad Wiebenga11, Blake A Simmons4,12, Miia R Mäkelä11,13, Ronald P de Vries11, Igor V Grigoriev2,14, Uffe H Mortensen1, Scott E Baker15,16, Mikael R Andersen17.
Abstract
Aspergillus section Nigri comprises filamentous fungi relevant to biomedicine, bioenergy, health, and biotechnology. To learn more about what genetically sets these species apart, as well as about potential applications in biotechnology and biomedicine, we sequenced 23 genomes de novo, forming a full genome compendium for the section (26 species), as well as 6 Aspergillus niger isolates. This allowed us to quantify both inter- and intraspecies genomic variation. We further predicted 17,903 carbohydrate-active enzymes and 2,717 secondary metabolite gene clusters, which we condensed into 455 distinct families corresponding to compound classes, 49% of which are only found in single species. We performed metabolomics and genetic engineering to correlate genotypes to phenotypes, as demonstrated for the metabolite aurasperone, and by heterologous transfer of citrate production to Aspergillus nidulans. Experimental and computational analyses showed that both secondary metabolism and regulation are key factors that are significant in the delineation of Aspergillus species.Entities:
Mesh:
Year: 2018 PMID: 30349117 DOI: 10.1038/s41588-018-0246-1
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330